Related Experiment Videos
Retroperitoneal sarcomas: Combined-modality treatment approaches
Chandrajit P Raut1, Peter W T Pisters
1Department of Surgery, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Journal of Surgical Oncology
|June 22, 2006
Summary
Retroperitoneal sarcomas (RPS) are rare cancers. While surgery is standard, incomplete resections lead to recurrence, prompting research into combined therapies for better outcomes.
Area of Science:
- Oncology
- Surgical Oncology
Background:
- Retroperitoneal sarcomas (RPS) represent a rare subset, comprising about 15% of all soft tissue sarcomas.
- Complete surgical resection is the primary treatment, but large, advanced tumors often lead to incomplete removal and local recurrence.
Purpose of the Study:
- To review current diagnostic and staging concepts for RPS.
- To outline evolving treatment strategies for managing RPS, focusing on improving local control and survival.
Main Methods:
- Literature review of current concepts and evolving treatment strategies.
- Analysis of diagnostic, staging, and management approaches for RPS.
Main Results:
- RPS are challenging due to size and advanced stage at diagnosis.
- Incomplete surgical resection is a significant factor in local tumor recurrence.
- Combined-modality therapies are under investigation to enhance local control.
Conclusions:
- Improved diagnostic and staging accuracy are crucial for RPS management.
- Multidisciplinary approaches and novel therapeutic strategies are needed to improve outcomes for patients with RPS.